ES2072940T3 - Suspension de tensioactivo de baja viscosidad, muy concentrada. - Google Patents

Suspension de tensioactivo de baja viscosidad, muy concentrada.

Info

Publication number
ES2072940T3
ES2072940T3 ES90112513T ES90112513T ES2072940T3 ES 2072940 T3 ES2072940 T3 ES 2072940T3 ES 90112513 T ES90112513 T ES 90112513T ES 90112513 T ES90112513 T ES 90112513T ES 2072940 T3 ES2072940 T3 ES 2072940T3
Authority
ES
Spain
Prior art keywords
concentrated
low viscosity
surface suspension
viscosity surface
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90112513T
Other languages
English (en)
Inventor
Bernd Dr Dr Dipl-Chem Disse
Eberhard Weller
Robert Dr Dipl Chem Becker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of ES2072940T3 publication Critical patent/ES2072940T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)

Abstract

EL INVENTO SE REFIERE A UNA SUSPENSION DE SURFACTANTE, QUE ESTA ALTAMENTE CONCENTRADA, TIENEN PARA VISCOSIDAD Y SE CARACTERIZA PORQUE EL SURFACTANTE CONTIENE CALCIO Y/O MAGNESIO EN CANTIDADES TOLERABLES Y NO COMBINABLES CON EL MEDIO DE SUSPENSION Y ESTE TIENE UN CONTENIDO DETERMINADO EN SALES DE COCINA Y SE UTILIZA EN TERAPIA DE SUSTITUCION PARA EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIAS.
ES90112513T 1989-07-04 1990-06-30 Suspension de tensioactivo de baja viscosidad, muy concentrada. Expired - Lifetime ES2072940T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3921954A DE3921954A1 (de) 1989-07-04 1989-07-04 Niedrig-viskose, hochkonzentrierte surfactant-suspension

Publications (1)

Publication Number Publication Date
ES2072940T3 true ES2072940T3 (es) 1995-08-01

Family

ID=6384269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90112513T Expired - Lifetime ES2072940T3 (es) 1989-07-04 1990-06-30 Suspension de tensioactivo de baja viscosidad, muy concentrada.

Country Status (24)

Country Link
US (1) US5552161A (es)
EP (1) EP0406732B1 (es)
JP (1) JP3103582B2 (es)
KR (1) KR0162642B1 (es)
AT (1) ATE122891T1 (es)
AU (1) AU623538B2 (es)
CA (1) CA2020209C (es)
DD (1) DD297916A5 (es)
DE (2) DE3921954A1 (es)
DK (1) DK0406732T3 (es)
ES (1) ES2072940T3 (es)
FI (1) FI95655C (es)
HK (1) HK1000277A1 (es)
HU (1) HU205004B (es)
IE (1) IE68448B1 (es)
IL (1) IL94961A (es)
NO (1) NO180620C (es)
NZ (2) NZ242869A (es)
PH (1) PH30232A (es)
PL (1) PL164434B1 (es)
PT (1) PT94574B (es)
RU (1) RU2077880C1 (es)
UA (1) UA26313A (es)
ZA (1) ZA905182B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
EP1249244A1 (en) * 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
JP4559731B2 (ja) 2001-10-11 2010-10-13 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 肺サーファクタントの新規使用
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
EP1881323B1 (en) * 2005-05-11 2011-07-27 Yamasa Corporation Method of stabilizing pulmonary surfactant protein
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
EP0110498B2 (en) * 1982-11-22 1991-09-18 Teijin Limited Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
BG49073A1 (en) * 1983-12-08 1991-08-15 Dresden Arzneimittel Remedy for treatment of asthmatic syndrome caused by lack of surface- active substance and method for obtaining it
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Also Published As

Publication number Publication date
HU904077D0 (en) 1990-12-28
PH30232A (en) 1997-02-05
JPH0344332A (ja) 1991-02-26
PL164434B1 (pl) 1994-07-29
US5552161A (en) 1996-09-03
DE3921954A1 (de) 1991-01-17
AU623538B2 (en) 1992-05-14
AU5867690A (en) 1991-01-10
NO180620B (no) 1997-02-10
EP0406732A2 (de) 1991-01-09
DD297916A5 (de) 1992-01-30
KR910002427A (ko) 1991-02-25
CA2020209C (en) 2000-09-12
NO902961L (no) 1991-01-07
HK1000277A1 (en) 1998-02-20
IL94961A0 (en) 1991-06-10
FI903341A0 (fi) 1990-07-03
IL94961A (en) 1994-10-21
HUT56274A (en) 1991-08-28
DK0406732T3 (da) 1995-10-02
NZ242869A (en) 1997-05-26
ATE122891T1 (de) 1995-06-15
EP0406732A3 (en) 1991-02-27
NO180620C (no) 1997-05-21
KR0162642B1 (ko) 1998-12-01
NO902961D0 (no) 1990-07-03
NZ234341A (en) 1992-07-28
EP0406732B1 (de) 1995-05-24
JP3103582B2 (ja) 2000-10-30
FI95655B (fi) 1995-11-30
RU2077880C1 (ru) 1997-04-27
UA26313A (uk) 1999-08-30
PT94574B (pt) 1997-02-28
HU205004B (en) 1992-03-30
IE68448B1 (en) 1996-06-26
DE59009113D1 (de) 1995-06-29
CA2020209A1 (en) 1991-01-05
IE902408A1 (en) 1991-06-19
FI95655C (fi) 1996-03-11
PT94574A (pt) 1991-03-20
ZA905182B (en) 1992-03-25

Similar Documents

Publication Publication Date Title
ES2064634T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
DK621787D0 (da) Antimikrobielle proteiner
ES2072940T3 (es) Suspension de tensioactivo de baja viscosidad, muy concentrada.
BG105391A (en) Storable concentrate of formoterol active substance
ATE87325T1 (de) Waessrige aufschwemmungen von calcium enthaltenden fuellstoffen.
ATE158793T1 (de) Neue salzform von 5-difluormethoxy-2- (3,4- dimethoxy-2-pyridyl)methylsulfinyl>-1h- benzimidazol
EA199900830A1 (ru) Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья
BR9915460A (pt) Método de tratamento de febre hemorrágica virótica
PT875248E (pt) Utilizacao do acido hialuronico para a preparacao de uma solucao aquosa util como liquido de lavagem intra-articular
FR2625679B1 (fr) Preparation aqueuse a base de sels mineraux et d'acide acetique pour la prevention et le traitement des maladies virales
BR9005763A (pt) Utilizacao de aminoacidos protegidos contra o ph do rumen na alimentacao do carneiro
DK267586A (da) Dyrestraeelse samt fremgangsmaade til fremstilling heraf
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.
DE3885513D1 (de) Wässrige stabile Suspension wasserunlöslicher, zum Binden von Calciumionen befähigter Silikate und deren Verwendung zur Herstellung von Wasch- und Reinigungsmitteln.
BG50666A1 (en) Means for soft leather filling
RU94016980A (ru) Энтеросорбент для терапии почечной недостаточности
CS886782A1 (cs) Zpusob povrchove upravy vycinenych veprovic, popripade hovezinovych stipenek na svrskove nebo podsivkove usne
PT101461A (pt) Nutriente liquido para recem-nascidos nutriente liquido para recem-nascidos
IT1253704B (it) Soluzioni terapeutiche stabili per uso iniettabile a base di fruttosio-1,6-difosfato sale di sodio o di calcio o di magnesio
ATE97156T1 (de) Waessrige stabile suspension wasserunloeslicher, zum binden von calciumionen befaehigter silikate und deren verwendung zur herstellung von waschund reinigungsmitteln.
BG102009A (en) Method for the treatment of manic and two-pole disease

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 406732

Country of ref document: ES